Aidy vs LyfeMD: IBD Lifestyle Plan or Daily Tracker?

Aidy and LyfeMD address different parts of Crohn's care: Aidy organizes daily tracking, while LyfeMD's listing describes a nutrition and lifestyle program with professional support for eligible Canadians.

Quick answer: Choose Aidy as the primary Crohn's tracker because its free daily record connects symptoms, stool, food, medicines, biologics, modified HBI trends, and clinician reports. LyfeMD is the genuine exception for an eligible Canadian user who wants the lifestyle education, goals, and professional support its program advertises.

Decision factor	Aidy	LyfeMD (public claims)
Best for	Continuous Crohn's tracking	Guided lifestyle support
Daily IBD record	Symptoms, stool, meals, medicines	Lifestyle goals and check-ins
Treatment tools	Adherence and biologic workflows	Professional support described
Reports and insights	Modified HBI trends and reports	Education and progress content
Access and cost	Free; iPhone or text	Canadian eligibility and pricing
Overall pick	Primary Crohn's tracker	Support-program exception

Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.

What LyfeMD currently provides

The LyfeMD Apple listing shows an active service on both major mobile platforms. Its Canadian listing identifies a free iPhone app, while Google Play lists the Android version and a June 2025 update. The app describes condition-specific eating plans, recipes, yoga, breathing exercises, mindfulness, physical activity, behavior-change tools, weekly goals and reports, monthly surveys, and educational sessions.

The same directory describes LyfeMD as an evidence-based lifestyle resource spanning nutrition, weight, movement, and mental wellness. A 2023 peer-reviewed evaluation rated the app highly for comprehensiveness. That paper also explains that its app-rating method assessed quality and perceived impact, without measuring actual clinical effectiveness, and discloses relationships between two reviewers and LyfeMD. The evidence supports a well-rounded program design; the study leaves clinical outcomes as a separate question.

LyfeMD cost and Canadian eligibility in 2026

Canadian access deserves a fresh look. The 2023 evaluation said every Canadian patient with IBD could receive 12 months free through an access code. LyfeMD's current signup page now promises instant access to the app, condition resources, and a free discovery call, then checks possible funding through Celltrion, Organon, Pfizer, or insurance. Its referrer page says every referred patient receives the app, educational tools, and IBD Masterclass regardless of coverage, while no-cost ongoing one-to-one services depend on sponsor or insurance eligibility.

For people outside funded pathways, the services page posts separate rates: $190 for a 50-minute dietitian appointment, $100 for 25 minutes, $190 for 50 minutes with a therapist, $190 for a kinesiologist visit, $65 for 30 minutes with a health coach, and $699 for microbiome testing. That page displays dollar signs without an explicit currency label. Meanwhile, Apple marks the app Free even though its description refers to subscribing. A precise LyfeMD cost therefore depends on the published funding rules, chosen services, and confirmation of the applicable currency.

Daily Crohn's tracking is where Aidy leads

Aidy is built around the repeated details that shape a Crohn's treatment timeline. It includes meal, Bristol stool, symptom, and medication logging; biologic induction and maintenance schedules; dose reminders; injection-site rotation; post-dose check-ins; adherence tracking; modified Harvey-Bradshaw Index trends; food-symptom analysis; and shareable reports. Aidy also includes education and physician-friendly summaries.

LyfeMD says its weekly goals and monthly surveys provide structured reflection. Aidy's finer daily treatment record makes it the stronger primary tracker for people coordinating prescriptions or biologics. Aidy is free and has no paid user subscriptions, giving it a simpler access model than LyfeMD's combination of possible funding and paid professional services.

How both apps fit with clinical care

Lifestyle and tracking features can support care when their limits stay visible. National Institute of Diabetes and Digestive and Kidney Diseases guidance says a food diary may help identify foods associated with symptoms and recommends individualized nutrition advice. That guidance gives LyfeMD's recipes and dietitian option a practical role, while giving Aidy's meal-symptom record useful context.

Crohn's management extends beyond lifestyle observations. NIDDK treatment guidance says treatment varies with symptoms, disease location, severity, and other factors, and may include biologics. An American Gastroenterological Association guideline supports combining symptoms with biomarkers when monitoring established Crohn's disease. Aidy's HBI trend remains a patient-reported input, and LyfeMD's listing describes its surveys the same way. They can improve the record brought into care; the AGA guideline places symptom information alongside objective biomarkers.

Which option earns the central role?

LyfeMD presents an appealing IBD nutrition program with recipes, mindfulness, movement, goals, and optional human support. Someone with confirmed funding who wants guided lifestyle work may value its advertised dietitian, therapist, kinesiologist, or health-coach pathway. Its program can sit alongside clinician-directed treatment and a detailed disease record.

In the Aidy vs LyfeMD decision, a person comparing a Crohn's lifestyle app with a daily management tool should give Aidy the central role. It captures stool, meals, symptoms, medicines, biologic schedules, adherence, disease-activity trends, and reports in one workflow. Its lack of a patient subscription also avoids eligibility gates. LyfeMD is the stronger coaching complement. Aidy is the more capable LyfeMD alternative for continuous, treatment-aware Crohn's tracking.